GSB Wealth Management’s SPDR S&P Biotech ETF XBI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $357 | Hold |
4
| – | – | ﹤0.01% | 239 |
|
|
2025
Q1 | $350 | Buy |
+4
| New | +$350 | ﹤0.01% | 227 |
|
|
2024
Q4 | – | Sell |
-4
| Closed | -$428 | – | 244 |
|
|
2024
Q3 | $428 | Buy |
+4
| New | +$428 | ﹤0.01% | 232 |
|
|
2023
Q2 | – | Sell |
-24
| Closed | -$1.97K | – | 236 |
|
|
2023
Q1 | $1.97K | Buy |
+24
| New | +$1.97K | ﹤0.01% | 214 |
|
|
2022
Q3 | – | Sell |
-3,023
| Closed | -$225K | – | 205 |
|
|
2022
Q2 | $225K | Sell |
3,023
-5,222
| -63% | -$389K | 0.08% | 196 |
|
|
2022
Q1 | $741K | Sell |
8,245
-18,397
| -69% | -$1.65M | 0.22% | 138 |
|
|
2021
Q4 | $2.98M | Buy |
26,642
+1,249
| +5% | +$140K | 0.86% | 30 |
|
|
2021
Q3 | $3.19M | Buy |
25,393
+860
| +4% | +$108K | 1.64% | 16 |
|
|
2021
Q2 | $3.32M | Buy |
24,533
+1,418
| +6% | +$192K | 1.03% | 20 |
|
|
2021
Q1 | $3.14M | Buy |
+23,115
| New | +$3.14M | 1.04% | 21 |
|